The U.S. rates of advanced prostate cancer continued to rise in men 50 and older after the U.S. Preventive Services Task Force (USPSTF) recommended in 2012 against prostate-specific antigen (PSA)-based screening for all men, an American Cancer Society study shows. Notably, the annual increase in men ages 50–74 with the most advanced stage disease after this recommendation (2012–2016) was more than twofold higher than that reported for the previous period (2008–2012). Conversely, there was a drop…
You must be logged in to read/download the full post.
The post Recommendation Against PSA Routine Screening May Have Contributed to Higher Rates of Advanced PC appeared first on BioNewsFeeds.